P
PBH icon

&Partners’s Prestige Consumer Healthcare PBH Stock Holding History

&Partners’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$621K Sell
13,127
-1,194
-8% -$61.4K ﹤0.01% 1712
2026
Q1 		$849K Buy
14,321
+5,537
+63% +$359K ﹤0.01% 1389
2025
Q4 		$542K Sell
8,784
-61
-0.7% -$3.73K ﹤0.01% 1567
2025
Q3 		$552K Buy
8,845
+3,408
+63% +$237K ﹤0.01% 1394
2025
Q2 		$435K Buy
5,437
+1,493
+38% +$125K ﹤0.01% 1416
2025
Q1 		$335K Buy
3,944
+456
+13% +$37.4K ﹤0.01% 1351
2024
Q4 		$271K Buy
+3,488
New +$271K ﹤0.01% 1385

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

&Partners's PBH Position: Q2 2026 in Review

&Partners reduced its Prestige Consumer Healthcare (PBH) stake by 8.3% in Q2 2026, selling an estimated $61.4K and leaving 13,127 shares worth $621K. The position accounts for ﹤0.01% of the portfolio, ranked #1712.

&Partners first reported a position in PBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $849K in Q1 2026. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • &Partners held 13,127 shares of Prestige Consumer Healthcare worth $621K as of Q2 2026.
  • &Partners sold 1,194 Prestige Consumer Healthcare shares in Q2 2026, an estimated $61.4K.
  • Prestige Consumer Healthcare made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1712 holding.
  • &Partners first reported a position in Prestige Consumer Healthcare in Q4 2024 and has held it in 7 quarters since.
  • &Partners's Prestige Consumer Healthcare position peaked at $849K in Q1 2026.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.